UBE2C 抗体
(Ubiquitin-Conjugating Enzyme E2C (UBE2C))
The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, or E1s, ubiquitin-conjugating enzymes, or E2s, and ubiquitin-protein ligases, or E3s. This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. This enzyme is required for the destruction of mitotic cyclins and for cell cycle progression. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2009].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| UBE2C 抗体 | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| UBE2C 抗体 | 人 | 兔 Polyclonal |
|
|
|
| UBE2C 抗体 (AA 121-179) | 人 | 小鼠 Monoclonal |
|
|
|
| UBE2C 抗体 (AA 101-179) | 人 | 兔 Polyclonal |
|
|
|
| UBE2C 抗体 (AA 101-179) (AbBy Fluor® 350) | 人 | 兔 Polyclonal |
|
|
|
| UBE2C 抗体 (AA 101-179) (AbBy Fluor® 594) | 人 | 兔 Polyclonal |
|
|
|
| UBE2C 抗体 (AA 101-179) (AbBy Fluor® 488) | 人 | 兔 Polyclonal |
|
|
|
| UBE2C 抗体 (AA 101-179) (AbBy Fluor® 555) | 人 | 兔 Polyclonal |
|
|
|
| UBE2C 抗体 (AA 101-179) (AbBy Fluor® 647) | 人 | 兔 Polyclonal |
|
|
|
| UBE2C 抗体 (AA 101-179) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| UBE2C 抗体 (AA 101-179) (AbBy Fluor® 750) | 人 | 兔 Polyclonal |
|
|
|
| UBE2C 抗体 (AA 101-179) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| UBE2C 抗体 (AA 101-179) (Cy5.5) | 人 | 兔 Polyclonal |
|
|
|
| UBE2C 抗体 (AA 101-179) (Cy7) | 人 | 兔 Polyclonal |
|
|
|
| UBE2C 抗体 (AA 101-179) (AbBy Fluor® 680) | 人 | 兔 Polyclonal |
|
|
|
| UBE2C 抗体 (AA 101-179) (Cy5) | 人 | 兔 Polyclonal |
|
|
|
| UBE2C 抗体 (AA 101-179) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| UBE2C 抗体 (AA 101-179) (Cy3) | 人 | 兔 Polyclonal |
|
|
|
| UBE2C 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| UBE2C 抗体 (AA 142-172) (Biotin) | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- H11J9
- 标记
- unconjugated
- 抗原表位
- AA 121-179
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 101-179
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 350
- 抗体亚型
- IgG
- 抗原表位
- AA 101-179
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 594
- 抗体亚型
- IgG
- 抗原表位
- AA 101-179
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 488
- 抗体亚型
- IgG
- 抗原表位
- AA 101-179
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 555
- 抗体亚型
- IgG
- 抗原表位
- AA 101-179
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 647
- 抗体亚型
- IgG
- 抗原表位
- AA 101-179
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 101-179
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 750
- 抗体亚型
- IgG
- 抗原表位
- AA 101-179
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 101-179
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy5.5
- 抗体亚型
- IgG
- 抗原表位
- AA 101-179
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy7
- 抗体亚型
- IgG
- 抗原表位
- AA 101-179
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 680
- 抗体亚型
- IgG
- 抗原表位
- AA 101-179
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy5
- 抗体亚型
- IgG
- 抗原表位
- AA 101-179
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 101-179
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy3
- 抗体亚型
- IgG
- 抗原表位
- AA 101-179
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 142-172
Latest Publications for our UBE2C 抗体
: "APLP2, RRM2, and PRC1: New Putative Markers for the Differential Diagnosis of Thyroid Follicular Lesions." in: Thyroid : official journal of the American Thyroid Association, Vol. 27, Issue 1, pp. 59-66, (2016) (PubMed).
: "Ubiquitin-conjugating enzyme UBE2C is highly expressed in breast microcalcification lesions." in: PLoS ONE, Vol. 9, Issue 4, pp. e93934, (2014) (PubMed).
: "Multicenter validation of cyclin D1, MCM7, TRIM29, and UBE2C as prognostic protein markers in non-muscle-invasive bladder cancer." in: The American journal of pathology, Vol. 182, Issue 2, pp. 339-49, (2013) (PubMed).
: "UBE2C is a marker of unfavorable prognosis in bladder cancer after radical cystectomy." in: International journal of clinical and experimental pathology, Vol. 6, Issue 7, pp. 1367-74, (2013) (PubMed).
: "Oligonucleotide microarray identifies genes differentially expressed during tumorigenesis of DMBA-induced pancreatic cancer in rats." in: PLoS ONE, Vol. 8, Issue 12, pp. e82910, (2013) (PubMed).
: "A study of UbcH10 expression and its association with recurrence of meningiomas." in: Journal of surgical oncology, Vol. 106, Issue 3, pp. 327-31, (2012) (PubMed).
: "Association of clinicopathological features with UbcH10 expression in colorectal cancer." in: Journal of cancer research and clinical oncology, Vol. 136, Issue 3, pp. 419-26, (2010) (PubMed).
: "Expression of ubiquitin-conjugating enzyme E2C/UbcH10 in astrocytic tumors." in: Brain research, Vol. 1201, pp. 161-6, (2008) (PubMed).
: "Dominant-negative cyclin-selective ubiquitin carrier protein E2-C/UbcH10 blocks cells in metaphase." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 94, Issue 6, pp. 2362-7, (1997) (PubMed).
: "Ubiquitin-conjugating enzyme UBE2C is highly expressed in breast microcalcification lesions." in: PLoS ONE, Vol. 9, Issue 4, pp. e93934, (2014) (PubMed).
: "Multicenter validation of cyclin D1, MCM7, TRIM29, and UBE2C as prognostic protein markers in non-muscle-invasive bladder cancer." in: The American journal of pathology, Vol. 182, Issue 2, pp. 339-49, (2013) (PubMed).
: "UBE2C is a marker of unfavorable prognosis in bladder cancer after radical cystectomy." in: International journal of clinical and experimental pathology, Vol. 6, Issue 7, pp. 1367-74, (2013) (PubMed).
: "Oligonucleotide microarray identifies genes differentially expressed during tumorigenesis of DMBA-induced pancreatic cancer in rats." in: PLoS ONE, Vol. 8, Issue 12, pp. e82910, (2013) (PubMed).
: "A study of UbcH10 expression and its association with recurrence of meningiomas." in: Journal of surgical oncology, Vol. 106, Issue 3, pp. 327-31, (2012) (PubMed).
: "Association of clinicopathological features with UbcH10 expression in colorectal cancer." in: Journal of cancer research and clinical oncology, Vol. 136, Issue 3, pp. 419-26, (2010) (PubMed).
: "Expression of ubiquitin-conjugating enzyme E2C/UbcH10 in astrocytic tumors." in: Brain research, Vol. 1201, pp. 161-6, (2008) (PubMed).
: "Dominant-negative cyclin-selective ubiquitin carrier protein E2-C/UbcH10 blocks cells in metaphase." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 94, Issue 6, pp. 2362-7, (1997) (PubMed).
Aliases for UBE2C 抗体
ubiquitin conjugating enzyme E2 C (UBE2C) 抗体ubiquitin-conjugating enzyme E2C (NAEGRDRAFT_82946) 抗体
ubiquitin conjugating enzyme E2 C L homeolog (ube2c.L) 抗体
ubiquitin-conjugating enzyme E2C (Ube2c) 抗体
ubiquitin conjugating enzyme E2 C S homeolog (ube2c.S) 抗体
ubiquitin-conjugating enzyme E2C (ube2c) 抗体
1110015A16Rik 抗体
D2Ertd695e 抗体
dJ447F3.2 抗体
im:7137135 抗体
LOC458287 抗体
UBCH10 抗体
zgc:123190 抗体
您还需要查找其他产品吗？
You are here:
